Eplerenone

CAT:
804-HY-B0251-01
Size:
5 mg

For Laboratory Research Only. Not for Clinical or Personal Use.

  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Eplerenone - image 1

Eplerenone

  • UNSPSC Description:

    Eplerenone (Epoxymexrenone) is a selective, highly specific and orally active aldosterone blocker (SAB). Eplerenone also is a selective mineralocorticoid receptor antagonist (MRA) with IC50 value of 0.081 μM. Eplerenone can be used for the research of hypertension, atherosclerosis, chronic systolic heart failure (HF) and cardiovascular (CV)[1][2].
  • Target Antigen:

    Endogenous Metabolite; Mineralocorticoid Receptor
  • Type:

    Reference compound
  • Related Pathways:

    Metabolic Enzyme/Protease;Vitamin D Related/Nuclear Receptor
  • Applications:

    COVID-19-immunoregulation
  • Field of Research:

    Cancer; Cardiovascular Disease
  • Assay Protocol:

    https://www.medchemexpress.com/eplerenone.html
  • Purity:

    99.81
  • Solubility:

    DMSO : 25 mg/mL (ultrasonic)
  • Smiles:

    O=C(CC1)O[C@@]21CC[C@@]3([H])[C@]4([H])[C@H](C(OC)=O)CC5=CC(CC[C@]5(C)[C@@]46[C@H](O6)C[C@@]32C)=O
  • Molecular Weight:

    414.49
  • References & Citations:

    [1]Dhillon, S., Eplerenone: a review of its use in patients with chronic systolic heart failure and mild symptoms. Drugs, 2013. 73(13): p. 1451-62.|[2]Myron H Weinberger, et al. Eplerenone, a selective aldosterone blocker, in mild-to-moderate hypertension. Am J Hypertens. 2002 Aug;15(8):709-16. |[3]Shlomo Keidar, et al. Effect of eplerenone, a selective aldosterone blocker, on blood pressure, serum and macrophage oxidative stress, and atherosclerosis in apolipoprotein E-deficient mice. J Cardiovasc Pharmacol. 2003 Jun;41(6):955-63.
  • Shipping Conditions:

    Room Temperature
  • Storage Conditions:

    -20°C, 3 years; 4°C, 2 years (Powder)
  • Clinical Information:

    Launched
  • CAS Number:

    107724-20-9